The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×

Sections

General Treatment Approaches | Lithium | Anticonvulsants | Antipsychotics | Benzodiazepines | Calcium Channel Blockers | Omega-3 Fatty Acids | Bibliography

Excerpt

The term mood stabilizer was first reported in relation to lithium salts when it became clear that they were effective not only in alleviating mania but also as a prophylaxis against both manic and depressive cycles. Since the introduction of lithium to the United States in 1969 there have been very few drugs approved as overall “mood stabilizers.” However, in more recent years drugs such as lamotrigine, olanzapine, quetiapine, and aripiprazole have been approved for the prevention of mania and depression in bipolar disorder. In addition, many medications have been approved for the acute treatment of mania, and the first drugs for the acute treatment of bipolar depression have now also been approved. It is somewhat less clear that any of the anticonvulsants currently used in treating bipolar affective disorder are as deserving of the term mood stabilizer as is lithium. However, the second-generation antipsychotics (SGAs) with clear benefits in the acute treatment and prevention of both mania and depression do appear deserving of such designation.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.
  • Institutional Login
  • Sign in via OpenAthens
  • Register for access
  • Please login/register if you wish to pair your device and check access availability.

    Not a subscriber?

    Subscribe Now / Learn More

    PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

    Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).